1. Home
  2. ZVRA

ZVRA

Zevra Therapeutics Inc.

Logo Zevra Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Founded: 2006 Country:
United States
United States
Employees: N/A City: CELEBRATION
Market Cap: 206.7M IPO Year: 2015
Target Price: $20.00 AVG Volume (30 days): 249.5K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.30 EPS Growth: N/A
52 Week Low/High: $3.89 - $7.28 Next Earning Date: 05-13-2024
Revenue: $27,461,000 Revenue Growth: 170.26%
Revenue Growth (this year): 8.97% Revenue Growth (next year): 209.15%

Share on Social Networks: